Acetabular reconstruction for primary and revision total hip arthroplasty using Kerboull-type acetabular reinforcement devices-case-control study with factors related to poor outcomes of surgery.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
Jul 2019
Historique:
entrez: 7 7 2019
pubmed: 7 7 2019
medline: 16 7 2019
Statut: ppublish

Résumé

Kerboull-type acetabular support rings (KT) and allogenic bone graft were used for severe periacetabular bone loss with primary and revision total hip arthroplasty (THA). The purpose of this case-control study is to evaluate the risk factors related to poor outcomes of surgery.Sixty patients underwent primary THA and revision THA using allogenic bone graft with KT for large acetabular deficiency. These patients were retrospectively evaluated postoperatively and followed-up by radiograph. The minimum follow-up period was 4 years and averaged 7 years. A radiological failure was defined by the following criteria:Expected risk factors were defined as female, age >75 years, body mass index (BMI) >25%, medical history of hypertension, renal failure, liver steatosis, diabetes, hyperlipidemia, cardiac infarction, smoking, American Academy of Orthopedic Surgery (AAOS) classification III or IV, bleeding>500 mL, time of surgery >3hours, high hip center-type KT, inclination of KT >45 degrees, screw angle >25 degrees, morselized bone graft, Kawanabe's classification stage 3 or 4 and revision surgery. Nineteen hips (31.6%) revealed radiological failure according to our criteria, and revision THA was performed in 2 hips (3.3%). In the statistical analysis, morselized bone graft and high hip center-type KT were identified as factors of poor outcomes of surgery.

Identifiants

pubmed: 31277106
doi: 10.1097/MD.0000000000016090
pii: 00005792-201907050-00021
pmc: PMC6635283
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e16090

Références

BMC Musculoskelet Disord. 2017 Sep 2;18(1):382
pubmed: 28865420
J Arthroplasty. 1994 Oct;9(5):469-79
pubmed: 7807103
J Arthroplasty. 1993 Aug;8(4):341-6
pubmed: 8409985
Acta Orthop Scand. 2001 Jun;72(3):221-7
pubmed: 11480594
J Bone Joint Surg Br. 2011 Sep;93(9):1194-200
pubmed: 21911530
J Bone Joint Surg Am. 1986 Oct;68(8):1241-8
pubmed: 3771605
Int Orthop. 2012 Jan;36(1):23-6
pubmed: 21574052
J Arthroplasty. 2010 Jun;25(4):594-9
pubmed: 19493654
J Bone Joint Surg Br. 1990 Jan;72(1):63-7
pubmed: 2298796
J Arthroplasty. 2017 Mar;32(3):908-914
pubmed: 27687810
J Arthroplasty. 2011 Oct;26(7):1061-6
pubmed: 21676579
J Bone Joint Surg Am. 1996 May;78(5):693-7
pubmed: 8642025
J Arthroplasty. 2017 Nov;32(11):3502-3509
pubmed: 28711340
J Arthroplasty. 2003 Sep;18(6):719-25
pubmed: 14513444
J Bone Joint Surg Am. 1997 Feb;79(2):159-68
pubmed: 9052535
J Bone Joint Surg Br. 1994 May;76(3):419-22
pubmed: 8175845
Int Orthop. 2014 May;38(5):947-51
pubmed: 24477474
Eur J Orthop Surg Traumatol. 2018 Apr;28(3):485-491
pubmed: 29026992
Bone Joint J. 2014 Mar;96-B(3):319-24
pubmed: 24589785
J Arthroplasty. 1997 Aug;12(5):503-10
pubmed: 9268789
J Bone Joint Surg Am. 1990 Dec;72(10):1536-40
pubmed: 2254363
J Bone Joint Surg Br. 1992 Sep;74(5):711-5
pubmed: 1527119
J Arthroplasty. 2015 Oct;30(10):1810-4
pubmed: 25981327
J Bone Joint Surg Br. 2007 Jan;89(1):26-31
pubmed: 17259411
Clin Orthop Relat Res. 2000 Sep;(378):155-68
pubmed: 10986990

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH